✦ LIBER ✦

T cell (CD3+) chimerism after non-myeloablative allogeneic hematopoietic stem cell transplantation (NMHSCT)

✍ Scribed by R. Sobecks; K. Theil; L. Rybicki; E. Kuczkowski; I. Warshawsky; R. Tubbs; M. Kalaycio; B. Pohlman; S. Andresen; B.J. Bolwell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-Myeloablative Allogeneic Hematopoiet

✍ Nonniekaye Shelburne; Margaret Bevans 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Infectious morbidity after non myeloabla

✍ A. Thiébaut; D. Antal; K. Bilger; M. Michallet; D. Fière 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Non-myeloablative hematopoietic stem cel

✍ M. Maris; B.M. Sandmaier; D.G. Maloney; P.A. McSweeney; A. Woolfrey; T. Chauncey 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 71 KB

Chronic Kidney Disease after Myeloablati

✍ Sabina Kersting; Ronald J. Hené; Hein A. Koomans; Leo F. Verdonck 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 503 KB

Chronic Kidney Disease after Myeloablati

✍ Henk B. Kal; M. Loes van Kempen-Harteveld 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Chimerism monitoring following allogenei

✍ Khan, F; Nityanand, S; Agrawal, S; Talwar, S 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 129 KB